News

  1. Ludovic Leloup (team cytoskeleton & neurophysiopathology) received a 30 000 € grant from the GEFLUC

    The Emergence project entitled “Tau, from Alzheimer disease to glioblastoma, evolution of a prognostic marker” was selected by the Canceropole PACA to be founded by the GEFLUC (groupement des entreprises françaises dans la lutte contre le cancer). Team 9 has a long-time expertise on Tau and this grant will be used to complete the identification of the kinases responsible for Tau phosphorylation in glioblastoma.

    Photo from the GEFLUC

  2. NeuroSchool: a School of Neuroscience for and by AMU students

    On September 12, over 300 students, teachers, researchers, clinicians and entrepreneurs participated in the launch of NeuroSchool, the school that unifies and harmonizes the teachings of the third year of the bachelor's degree (Neuroscience path), the master's degree and the PhD program in neuroscience. Funded by the National Research Agency and the A*Midex Foundation, NeuroSchool will benefit from a funding of approximately 10 million euros (over 10 years).

  3. Michel Khrestchatisky and Grigorios Kyriatzis (Early Stage Researcher, ESR), both members of the ITN Marie Curie project ECMED participated in the ECMED EU-GliaPhD international conference organized in Malta

    Michel Khrestchatisky gave a talk on the ongoing projects of his group and biotechnology partner Vect-Horus, also member of the ECMED consortium, while Grigorios Kyriatzis presented results of his ongoing PhD project.       

  4. François Devred gave one of the 38 selected talks in EUROTAU 2018

    #EUROTAU 2018 - European scientists involved in Tau research met in Lille to exchange new ideas and hypotheses on physiological and pathological roles of tau proteins (26-27th April 2018). François Devred gave one of the 38 selected talks in which he presented a new reversible oligomerization of tau protein evidenced in INP team 9, which could have a protective physiological role and prevent pathological aggregation of tau in neurodegenerative diseases. Next edition of EuroTau will be in 2020.

    Photo © Valérie Buée Scherrer

  5. The Viewpoint article by C. Leterrier was selected for the cover image of The Journal of Neuroscience , 2018 February 28 issue
  6. An image from the NeuroCyto team exhibited on the CNRS "Étonnant Vivant" fresco

INP in numbers

  • 126 members
  • 44 researchers
  • 48 research assistants
  • 12 post-docs
  • 11 PhD

 

Ludovic Leloup (team cytoskeleton & neurophysiopathology) received a 30 000 € grant from the GEFLUC

The Emergence project entitled “Tau, from Alzheimer disease to glioblastoma, evolution of a prognostic marker” was selected by the Canceropole PACA to be founded by the GEFLUC (groupement des entreprises françaises dans la lutte contre le cancer). Team 9 has a long-time expertise on Tau and this grant will be used to complete the identification of the kinases responsible for Tau phosphorylation in glioblastoma.

Photo from the GEFLUC

Undefined

NeuroSchool: a School of Neuroscience for and by AMU students

On September 12, over 300 students, teachers, researchers, clinicians and entrepreneurs participated in the launch of NeuroSchool, the school that unifies and harmonizes the teachings of the third year of the bachelor's degree (Neuroscience path), the master's degree and the PhD program in neuroscience. Funded by the National Research Agency and the A*Midex Foundation, NeuroSchool will benefit from a funding of approximately 10 million euros (over 10 years).

Undefined

Michel Khrestchatisky and Grigorios Kyriatzis (Early Stage Researcher, ESR), both members of the ITN Marie Curie project ECMED participated in the ECMED EU-GliaPhD international conference organized in Malta

Michel Khrestchatisky gave a talk on the ongoing projects of his group and biotechnology partner Vect-Horus, also member of the ECMED consortium, while Grigorios Kyriatzis presented results of his ongoing PhD project.       

Undefined

François Devred gave one of the 38 selected talks in EUROTAU 2018

#EUROTAU 2018 - European scientists involved in Tau research met in Lille to exchange new ideas and hypotheses on physiological and pathological roles of tau proteins (26-27th April 2018). François Devred gave one of the 38 selected talks in which he presented a new reversible oligomerization of tau protein evidenced in INP team 9, which could have a protective physiological role and prevent pathological aggregation of tau in neurodegenerative diseases. Next edition of EuroTau will be in 2020.

Photo © Valérie Buée Scherrer

Undefined

The Viewpoint article by C. Leterrier was selected for the cover image of The Journal of Neuroscience , 2018 February 28 issue

This image shows cultured hippocampal neurons labeled for dendrites (MAP2, blue), and for the axon initial segment (yellow is an overlay of neurofascin-186, green and β4-spectrin, red). For more information, see the Viewpoint article.

English

An image from the NeuroCyto team exhibited on the CNRS "Étonnant Vivant" fresco

From November 2017 to March 2018, the CNRS exhibited an amazing fresco of 134 metres long on the most surprising living discoveries of the last 15 years along the corridor of the Montparnasse-Bienvenüe subwway station in Paris. A picture of an hippocampal neuron from the NeuroCyto team was featured to illustrate the neurosciences. More here (in French).

English

The CNRS press office selected one of our pictures to illustrate a press release about the fresco "étonnant vivant"

In the corridor of the Montparnasse-Bienvenüe Station, the CNRS exhibits an amazing fresco of 134 metres long on the most surprising living discoveries of the last 15 years.  One of our pictures, featured on the fresco has been selected by the CNRS press office to illustrate a press release entitled "« Étonnant Vivant » : une nouvelle exposition à la station Montparnasse-Bienvenüe"

English

Next seminars

19 Oct 2018 14:30

Jean-Philippe Dales - « “Leaky brain” and gluten, is there a connection ? »

Faculté de médecine Nord, salle de conférences, bâtiment E

Jean-philippe Dales is MCU in the team 5 - Neuro-inflammation and Multiple Sclerosis.

9 Nov 2018 14:30

Thomas Perez - "Analyse des effets pharmacologiques d’un inhibiteur d’HDAC dans les glioblastomes"

Faculté de pharmacie de la Timone

Thomas Perez is a PhD student in the Team 8 - GlioME: Gliomagenesis and MicroEnvironment.

Partners